FR940317-0-00040 FR940317-0-00014 21 CFR Part 558 New Animal Drugs for Use in Animal Feeds; Salinomycin AGENCY: Food and Drug Administration, HHS. ACTION: Final rule. SUMMARY: The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of an abbreviated new animal drug application (ANADA) filed by Hoechst-Roussel Agri-Vet Co. The ANADA provides for making a Type A medicated article containing salinomycin used to make a Type C medicated broiler feed for the prevention of coccidiosis in broiler chickens. EFFECTIVE DATE: March 17, 1994. FOR FURTHER INFORMATION CONTACT: Melanie R. Berson, Center for Veterinary Medicine (HFV&hyph;135), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 301&hyph;594&hyph;1643. SUPPLEMENTARY INFORMATION: Hoechst-Roussel Agri-Vet Co., P.O. Box 2500, Somerville, NJ 08876&hyph;1258, filed ANADA 200&hyph;075 which provides for making a 30 grams (g) per pound salinomycin Type A medicated article used to make a Type C medicated broiler feed containing 40 to 60 g of salinomycin per ton. The feed is used for the prevention of coccidiosis caused by Eimeria acervulina , E. brunetti , E. maxima , E. mivati , E. necatrix , and E. tenella in broiler chickens. ANADA 200&hyph;075 for Hoechst-Roussel's salinomycin Type A article is as a generic copy of Agri-Bio Corp.'s Bio-Cox (salinomycin Type A article) in a new animal drug application (NADA 128&hyph;686). The ANADA is approved as of February 23, 1994, and the regulations are amended in 21 CFR 558.550(a) to reflect the approval. The basis for approval is discussed in the freedom of information summary. In accordance with the freedom of information provisions of part 20 (21 CFR part 20) and ยง514.11(e)(2)(ii) (21 CFR 514.11(e)(2)(ii), a summary of safety and effectiveness data and information submitted to support approval of this application may be seen in the Dockets Management Branch (HFA&hyph;305), Food and Drug Administration, rm. 1&hyph;23, 12420 Parklawn Dr., Rockville, MD 20857, between 9 a.m. and 4 p.m., Monday through Friday. The agency has carefully considered the potential environmental effects of this action. FDA has concluded that the action will not have a significant impact on the human environment, and that an environmental impact statement is not required. The agency's finding of no significant impact and the evidence supporting that finding, contained in an environmental assessment, may be seen in the Dockets Management Branch (address above) between 9 a.m. and 4 p.m., Monday through Friday. List of Subjects in 21 CFR Part 558 Animal drugs, Animal feeds. Therefore, under the Federal Food, Drug, and Cosmetic Act and under the authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR part 558 is amended as follows: PART 558_NEW ANIMAL DRUGS FOR USE IN ANIMAL FEEDS 1. The authority citation for 21 CFR part 558 continues to read as follows: Authority: Secs. 512, 701 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360b, 371). 2. Section 558.550 is amended by revising paragraph (a) to read as follows: ยง558.550 Salinomycin. (a) Approvals . Type A medicated article with 30 grams of activity per pound from salinomycin sodium biomass: To 012799 in ยง510.600(c) of this chapter for use as in paragraph (b)(1)(i) of this section; to 042835 in ยง510.600(c) of this chapter for use as in paragraph (b) of this section. * * * * * Dated: March 10, 1994. Richard H. Teske, Acting Director, Center for Veterinary Medicine. [FR Doc. 94&hyph;6225 Filed 3&hyph;16&hyph;94; 8:45 am] BILLING CODE 4160&hyph;01&hyph;F
